Skip to main content
Equibles

LABT

Lakewood-Amedex Biotherapeutics Inc.
Going-concern doubt — flagged May 22, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, substantial doubt regarding the Company’s ability to continue as a going concern within one year after the date that these financial statements are issued has not been alleviated.”
View the 10-Q filed May 22, 2026

Company with tickers: LABT

CIK
2079272
CUSIP
51255A102
Shares Outstanding
6,995,469

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Past events

Date Event Type
2026-06-22 Lakewood-Amedex Biotherapeutics Secures Composition of Matter Patent Protecting New Bisphosphocin® Compounds Being Developed for High-Need Antimicrobial Infections Event
2026-06-16 Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum Event
2026-05-27 Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers Event
2026-05-18 Lakewood-Amedex Biotherapeutics Announces Positive Data for the Advancement of Lead Candidate, Nu-3, in Infected Diabetic Foot Ulcers Event
2026-05-12 Lakewood-Amedex Biotherapeutics Announces Agreement with PERI to Serve as CRO for Phase 2 Clinical Trial of Nu-3 Event
2026-05-01 Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data for Lead Candidate Targeting Infected Diabetic Foot Ulcers Event
2026-04-28 Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors Event
2026-04-23 Lakewood-Amedex Biotherapeutics Announces Direct Listing on Nasdaq; Shares Trading Under the Symbol "LABT" Event
2025-11-03 Lakewood-Amedex Biotherapeutics to Participate in Panel Discussion at BioFlorida's "Florida Innovation Conference" Conference
2025-10-22 Lakewood-Amedex Biotherapeutics Announces Peer-Reviewed Publication Demonstrating Potent Antimicrobial Activity of Bisphosphocin® Class Against Resistant Pathogens Event
2025-09-30 Lakewood-Amedex Biotherapeutics to Present at BioFlorida Regional Event at The Roskamp Institute Event
2025-02-12 Lakewood-Amedex Names Douglas Manion, M.D., FRCP (C), as Chairman of the Board of Directors Event
2023-11-01 Lakewood-Amedex Announces Leadership Changes Event
2022-01-25 Lakewood-Amedex Appoints Two New Board Members Event
2020-07-21 Lakewood-Amedex Therapeutics Announces the Election of Peter B. Corr, Ph.D., as Chairman of the Board of Directors Event

Report a Problem

Category
Description
Email (optional, for follow-up)